[Current status of diagnosis of the cerebrospinal-fluid space using Amipaque (metrizamide)].
A report is given on 73 examinations using Metrizamide (8 thoracolumbar myelographies, 18 ventriculographies, 47 suboccipital myelographies) under consideration of the latest literature. Subsequent systematic EEG-controls were carried out in 52 patients. Exact observance of the indication, adequate dosage, optimum preparation and after-treatment of the patients as well as a appropriate operation technique can limitate the vegetativ side-effects and avoid rarely occurring serious complications. Publications in the literature as well as our own experiences stress the excellent representation of the details of the ventricular system and the spinal subarachnoid space.
D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging*; D002551:Cerebral Ventricle Neoplasms / Q000000981:diagnostic imaging; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D008793:Metrizamide; D009192:Myelography / Q000379:methods*; D013116:Spinal Cord / Q000000981:diagnostic imaging; D013346:Subarachnoid Space / Q000000981:diagnostic imaging
D008793:Metrizamide
Aktueller Stand der Diagnostik des Liquorraums mit Amipaque (Metrizamide).